Radial artery angiographic string sign: clinical consequences and the role of pharmacologic therapy

Senri Miwa1, Nimesh Desai, Tadaaki Koyama

  • 1Division of Cardiovascular Surgery, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.

Insights

Radial artery grafts can develop a "string sign," a diffuse narrowing, in 7% of patients after coronary artery bypass surgery. Despite this, over half of these grafts maintained adequate blood flow (TIMI 2 or better).

Area of Science:

  • Cardiovascular Surgery
  • Vascular Grafts
  • Interventional Cardiology

Background:

  • The radial artery is increasingly utilized as a graft in coronary artery bypass grafting (CABG).
  • Postoperative angiography reveals a subset of radial artery grafts exhibit diffuse narrowing, termed "string signs."

Purpose of the Study:

  • To investigate the incidence and characteristics of radial artery graft string signs.
  • To correlate string sign presence with medication, perioperative factors, and clinical outcomes.

Main Methods:

  • Postoperative angiography at 1 year in 440 patients receiving radial artery grafts.
  • Visual and quantitative analysis of angiograms to define complete and partial string signs.
  • Correlation of angiographic findings with medication compliance and clinical sequelae.

Main Results:

  • Radial artery grafts showed a 7.0% incidence of string signs, significantly higher than saphenous vein grafts (0.9%).
  • Complete string signs (mean diameter 0.76 mm) were more common than partial signs (0.89 mm).
  • Radial artery string signs were associated with perioperative alpha-adrenergic agonist use and target vessel stenosis <90%; 52% had TIMI 2 or better flow.

Conclusions:

  • The radial artery string sign occurs in 7% of patients undergoing CABG.
  • Despite diffuse narrowing, a significant proportion of radial artery grafts maintain acceptable blood flow.
  • String sign presence, particularly with TIMI 1 flow, is linked to adverse postoperative symptoms.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...